Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Share News (HLN)

Share Price Information for Haleon (HLN)

Share Price is delayed by 15 minutes
Get Live Data
361.80    1.60 (0.44%)
Bid:
362.20
Ask:
362.40
Spread: 0.20 (0.055%)
Market Cap: £31.87b
HLN Live PriceLast checked at - London Stock Exchange

Intraday Haleon Share Chart

Haleon News

Barclays upgrades Haleon to 'overweight'
7 Dec 2022

Barclays upgrades Haleon to 'overweight'

(Sharecast News) - Barclays upgraded Haleon on Wednesday to 'overweight' from 'equalweight' after a US Court threw out lawsuits alleging that GSK's fo...

LONDON MARKET MIDDAY: Stocks slide amid risk-off mood after China data
7 Dec 2022

LONDON MARKET MIDDAY: Stocks slide amid risk-off mood after China data

(Alliance News) - Stocks in Europe were mostly in the red on Wednesday, as economic data from China stoked fear of a global slowdown, while the FTSE 1...

LONDON BROKER RATINGS: Jefferies cuts PageGroup but keeps Hays at buy
7 Dec 2022

LONDON BROKER RATINGS: Jefferies cuts PageGroup but keeps Hays at buy

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday afternoon:

LONDON MARKET OPEN: Pharmaceutical stocks led by GSK spare FTSE 100
7 Dec 2022

LONDON MARKET OPEN: Pharmaceutical stocks led by GSK spare FTSE 100

(Alliance News) - Stock prices in London mostly opened flat on Wednesday, with falls in FTSE 100 housebuilders, miners and oil majors offset by gains ...

LONDON BRIEFING: Stocks called flat on mixed news from China
7 Dec 2022

LONDON BRIEFING: Stocks called flat on mixed news from China

(Alliance News) - Stocks in London were set to start flat on Wednesday, as weak economic data from China pointed to a "deep malaise" in the global eco...

TOP NEWS: GSK welcomes Zantac legal boost in Florida
6 Dec 2022

TOP NEWS: GSK welcomes Zantac legal boost in Florida

(Alliance News) - GSK PLC on Tuesday welcomed a US verdict in a lawsuit which had claimed the Zantac heartburn drug caused cancer.

Less deal-making, fewer IPOs but FTSE 100 shines in tumultuous 2022
2 Dec 2022

Less deal-making, fewer IPOs but FTSE 100 shines in tumultuous 2022

(Alliance News) - Liberum described 2022 as a "tale of two indices", with the FTSE 100 resilient in the face of global turmoil, but the FTSE 250 succu...

LONDON BROKER RATINGS: Credit Suisse cuts Vodafone; Citi likes BP
22 Nov 2022

LONDON BROKER RATINGS: Credit Suisse cuts Vodafone; Citi likes BP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: